DX-182

N/A

Report date: 2024/12/02 11:05:59

Base Information

Drug NameDX-182

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedRadiation-emitting products > Radioactive diagnostic agent

Mechanisms of ActionRadionuclide imaging enhancersFibrin modulators

TargetsFibrinogen

Therapy Area/IndicationsThrombosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesDyax

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesDyax Corp

Active IndicationsN/A

Inactive IndicationsThrombosis

Other Information

ATC CodeN/A